Conferences  >  Life Sciences  >  Molecular Biology  >  United Kingdom

The Company of Biologists Ltd

This Workshop unites experts in human cell fate engineering and experts in the manipulation and characterisation of single cells. The goal is to fully understand the molecular steps underlying the transformation of one cellular identity into another. The cross-disciplinary selection of speakers spans the fields of cell fate engineering and emerging technologies to analyse and manipulate cells at single-cell resolution.

Direct lineage reprogramming approaches, Assessment of reprogramming inefficiency and infidelity, Engineering cells with defined identity through new methods, De novo predictions of factors and conditions for target cell type generation

Oxford Global Conferences

Engage with esteemed pharmaceutical & biotech representatives as well as thought-leaders from academic & research institutions onsite and benefit from attending over 60 presentations. We will be welcoming onsite over 300 delegates for two days of cutting-edge scientific sessions and case studies bringing the latest biologics developments to the forefront of research.

Oxford Global Conferences;     Phone: [+44 1865 248455];     Email: info@oxfordglobal.co.uk

Antibody-Based Molecular Engineering, Emerging Techniques for Bioanalysis & Characterisation and Quality Control Systems, Track 1: Computational Tools, AI/ML & Structural Approaches & inEngineering, Multi Specific Antibodies, Cell Engagers & Other New Modalities

Oxford Global Conferences

Gene Therapy Development & Manufacturing 2023 delivers in-depth discussion on optimised process strategies and technologies for the successful technical development and manufacture of advanced gene therapy products.

Phone: [+44 1865 248455];     Email: h.liddiard@oxfordglobal.co.uk

Gene therapy, biology, vector development, gene editing, personalised medicine

Cambridge Healthtech Institute

The ubiquitin-proteasome, lysosome and autophagy systems are all well-controlled, selective degradation pathways that are key cellular regulators in cancer, CNS, and other diseases. A new generation of hetero bi-functional chimeras and small molecule monovalent degraders are being developed to hijack these systems for targeted protein degradation or stabilization. These molecules that include Proteolysis-targeting chimeras (PROTACs) and molecular glues are being used to seek out previously “undruggable” targets for therapeutic intervention. However, challenges do exist in terms of specificity, stability, biodistribution and penetration of these degrader molecules. This conference on Next-Generation Degraders & Glues brings together experts in the field to discuss these new therapeutic modalities, as well as issues underlying the use of targeted degradation as a new therapeutic approach.

Marketing Manager;     Email: aorktiese@healthtech.com

PROTACs, Molecular Glues, Protein Degradation

European Molecular Biology Organization – EMBO

Biology,    Microscopy

European Molecular Biology Organization – EMBO

Biology,    Microscopy

Isaac Newton Institute for Mathematical Sciences (INI)